Introduction to the Business of Medical Chemistry Drug Discovery Co., Ltd.
We will contribute to the advancement of glycan research and promote the health of humanity and society through drug discovery.
Ika Kagaku Sōyaku Co., Ltd. is a company that develops its business centered around reagent sales, glycan contract analysis, and glycan contract synthesis. We aim for drug discovery using our four core technologies: "GlycoBlotting method," "glycopeptide synthesis," "microparticle production technology," and "glycopeptide array." If you have any inquiries regarding glycan synthesis or analysis, please feel free to contact Ika Kagaku Sōyaku. 【Business Introduction】 ■Reagent Sales ■Glycan Analysis ■Glycan Synthesis ■Protein Quality Control *For more details, please refer to our catalog or feel free to contact us.
- Company:医化学創薬
- Price:Other